Advertisement
Advertisement

HALO

HALO logo

Halozyme Therapeutics, Inc.

63.96
USD
Sponsored
+0.30
+0.47%
May 01, 16:00 UTC -4
Closed
exchange

After-Market

63.97

+0.01
+0.01%

Halozyme Therapeutics, Inc. Financial Snapshot

Market Cap
7.58B
Beta
1.03
Earnings Per Share (EPS)
2.49
Price-to-Book (P/B) Ratio
161.60
Operating Margin
33.33%
Total Debt/Equity (D/E)
4389.38%
P/E Ratio
17.75
Return on Equity (ROE)
136.12%
Current Ratio
4.66%
Free Cash Flow
644.59M

Earnings Chart

Trending Stocks

Advertisement